8 | Peptides (Polypeptides)IBA
01/2021
-
05/2013 |
5 | Folic Acid (Vitamin M)FDA LinkGeneric
01/2021
-
01/2018 |
4 | AcidsIBA
01/2021
-
01/2018 |
3 | LigandsIBA
01/2021
-
01/2017 |
3 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2019
-
08/2014 |
2 | Glutamine (L-Glutamine)FDA Link
01/2022
-
01/2020 |
2 | Cardiac MyosinsIBA
01/2021
-
11/2020 |
2 | Proteins (Proteins, Gene)FDA Link
01/2021
-
01/2017 |
2 | N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2021
-
01/2017 |
2 | Cell Surface ReceptorsIBA
01/2021
-
12/2019 |
2 | LectinsIBA
01/2021
-
01/2017 |
2 | Freund's AdjuvantIBA
01/2021
-
11/2020 |
2 | Glucagon-Like Peptide-1 ReceptorIBA
01/2021
-
12/2020 |
2 | AluminumIBA
11/2020
-
01/2018 |
2 | Sialic Acid Binding Immunoglobulin-like LectinsIBA
01/2019
-
01/2017 |
2 | Matrix Metalloproteinases (MMPs)IBA
12/2018
-
01/2018 |
2 | Somatostatin Receptors (Somatostatin Receptor)IBA
02/2016
-
08/2014 |
2 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2016
-
08/2014 |
1 | AminopterinIBA
01/2021 |
1 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021 |
1 | IntegrinsIBA
01/2021 |
1 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
01/2021 |
1 | Glucose (Dextrose)FDA LinkGeneric
01/2021 |
1 | Methionine (L-Methionine)FDA Link
01/2021 |
1 | aspartic acid glycine arginineIBA
01/2021 |
1 | Hematoxylin (Haematoxylon)IBA
01/2020 |
1 | LuciferasesIBA
01/2020 |
1 | Eosine Yellowish-(YS) (Eosin)IBA
01/2020 |
1 | Complement System Proteins (Complement)IBA
12/2019 |
1 | Metalloproteases (Metalloproteinases)IBA
12/2018 |
1 | TurpentineIBA
01/2018 |
1 | GelatinasesIBA
01/2018 |
1 | 68Ga-DOTA-PeptideIBA
01/2018 |
1 | Immunoglobulins (Immunoglobulin)IBA
01/2017 |
1 | (18F)FEMPAIBA
01/2017 |
1 | MannansIBA
09/2016 |
1 | Fluorine-18IBA
09/2016 |
1 | Biological ProductsIBA
09/2016 |
1 | Insulin-Like Growth Factor II (Somatomedin A)IBA
02/2016 |
1 | Apolipoprotein B-100 (Apo B 100)IBA
02/2016 |
1 | Edotreotide (SMT 487)IBA
08/2014 |
1 | NOC 18IBA
08/2014 |
1 | 3-Tyr-octreotideIBA
08/2014 |